Difficulty: Medium
Average Score: 91%
Practice
An appropriate initial treatment for benign positional vertigo is:
Correct answer
B
Rationale
In the context of pharmacology and the treatment of benign positional vertigo, the correct initial treatment option of B) Meclizine (Antivert) is supported by its mechanism of action as an antihistamine with anticholinergic properties. Meclizine helps to reduce vestibular stimulation and alleviate vertigo symptoms by acting on the central nervous system.
Hydrochlorothiazide (A) is a diuretic primarily used for managing hypertension and fluid retention, not vertigo. Pseudoephedrine (C) is a nasal decongestant and not indicated for vertigo treatment. Promethazine (D) is an antihistamine with sedative effects, mainly used for allergies and nausea, but not for vertigo.
Educationally, it's important to understand the rationale behind the selection of the appropriate medication for specific conditions to optimize patient care outcomes. Understanding the mechanism of action and pharmacological properties of drugs helps healthcare professionals make informed decisions in selecting the most effective treatment options for patients with benign positional vertigo.
Hydrochlorothiazide (A) is a diuretic primarily used for managing hypertension and fluid retention, not vertigo. Pseudoephedrine (C) is a nasal decongestant and not indicated for vertigo treatment. Promethazine (D) is an antihistamine with sedative effects, mainly used for allergies and nausea, but not for vertigo.
Educationally, it's important to understand the rationale behind the selection of the appropriate medication for specific conditions to optimize patient care outcomes. Understanding the mechanism of action and pharmacological properties of drugs helps healthcare professionals make informed decisions in selecting the most effective treatment options for patients with benign positional vertigo.